These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1154334)

  • 1. On platelet fibrinogen in plasma defibrinogenated dogs and in uremic patients before and after hemodialysis.
    Johnsson H
    Thromb Res; 1975 Jul; 7(1):161-74. PubMed ID: 1154334
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
    Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
    Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis.
    Jørgensen KA; Ingeberg S
    Nephron; 1979; 23(5):233-6. PubMed ID: 481658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma administration to defibrinogenated dogs during extracorporeal circulation.
    Berglin E; Hansson HA; William-Olsson G
    Artif Organs; 1979 Feb; 3(1):80-5. PubMed ID: 435130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference on the haemostasis in dogs with induced coagulopathies by drugs affecting the platelet function.
    Johnsson H; Olsson P
    Haemostasis; 1976; 5(1):27-37. PubMed ID: 1269996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of moderate doses of chlorpromazine on the haemostasis in dogs defibrinogenated with defibrase.
    Johnsson H; Niklasson PM
    Thromb Res; 1974 Feb; 4(2):229-36. PubMed ID: 4831001
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation studies during therapeutic application of arvin.
    Vinazzer H
    Thromb Res; 1976 Feb; 8(2):243-8. PubMed ID: 943132
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemostatic clot formation at anastomosis of synthetic venous graft in defibrinogenated dogs: a scanning electron microscopic study.
    Ishimaru S; Berglin E; Hansson HA; Teger-Nilsson AC; William-Olsson G
    Thromb Haemost; 1981 Jun; 45(3):276-81. PubMed ID: 7025342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialyzable factors from uremic serum increase 125I-fibrinogen binding by normal blood platelets.
    Komarnicki M; Krupa D; Kaźmierczak M; Drobnik D; Zozulińska M
    Nephron; 1990; 55(4):372-4. PubMed ID: 2202919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen fragments and platelet dysfunction in uremia.
    Kozek-Langenecker SA; Masaki T; Mohammad H; Green W; Mohammad SF; Cheung AK
    Kidney Int; 1999 Jul; 56(1):299-305. PubMed ID: 10411706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beginning of repeated hemodialysis treatment enhances some platelet functions in uremic patients.
    Krawczyk W; Dmoszýnska A; Marczewski K
    Nephron; 1995; 71(3):361-2. PubMed ID: 8569990
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of hypofibrinogenemia with batroxobin on rat Masugi nephritis.
    Tomita K; Muso E; Tamura T; Kawai C
    Jpn Circ J; 1982 Jun; 46(6):577-82. PubMed ID: 7045444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of 125I-fibrinogen to blood platelets in patients with chronic uraemia.
    Komarnicki M; Zozulińska M; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):638-41. PubMed ID: 2448203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of plasma to dogs defibrinogenated with defibrase.
    Berglin E; Svalander C; Teger-Nilsson AC; William-Olsson G
    Thromb Res; 1978 Nov; 13(5):785-98. PubMed ID: 741451
    [No Abstract]   [Full Text] [Related]  

  • 15. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension.
    Noris M; Benigni A; Boccardo P; Aiello S; Gaspari F; Todeschini M; Figliuzzi M; Remuzzi G
    Kidney Int; 1993 Aug; 44(2):445-50. PubMed ID: 8377388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet associated IgG in uremia.
    Thomsen S; Giuliani D; Chang D; Lasker N; Morse BS
    Clin Nephrol; 1983 Sep; 20(3):136-9. PubMed ID: 6685006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin-stabilizing factor: a thrombin-labile platelet protein.
    Kiesselbach TH; Wagner RH
    Am J Physiol; 1966 Dec; 211(6):1472-6. PubMed ID: 4959531
    [No Abstract]   [Full Text] [Related]  

  • 20. Human platelet fibrinogen: a protein different from plasma fibrinogen.
    Soria J; Soria C; Samama M; Poirot E; Kling C
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():15-7. PubMed ID: 796805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.